- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07946640
A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults
This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.
All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jamie Bassmann
- E-mail: jamie.bassmann@driscolls.com
Lieux d'étude
-
-
Nevada
-
Las Vegas, Nevada, États-Unis, 89101
- Citruslabs
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Be male or female.
- Adult aged 18-65 years.
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- Willing and able to wear a CGM device continuously for the two-week study period.
- Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
- Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
- Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
- Have access to a smartphone or computer with a reliable internet connection.
- Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
- Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
- Resides in the United States.
Exclusion Criteria:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
- Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
- Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
- Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
- Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
- Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
- Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
- Pregnant, breastfeeding, or planning to become pregnant during the study period.
- Anyone with a history of substance abuse.
- Anyone who is currently a smoker or has been a smoker in the past three months.
- Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
- History of an eating disorder currently requiring active clinical treatment.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Driscoll's Blackberries Arm
|
All participants complete all three meal conditions in any sequence. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Délai: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal |
Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Délai: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal |
Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Self-Reported Hunger
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Fullness
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Desire to Eat
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Energy Levels
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Digestive Comfort
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Change in Self-Reported Bloating
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Perceived Sweetness of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Palatability of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Motivation to Eat Healthier the Rest of the Day
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
|
Self-Reported Overall Acceptability of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Assessed via self-reported questionnaire administered through the Citruslabs digital study platform |
End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- DRISC-40019
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .